315 related articles for article (PubMed ID: 26493712)
1. Toxicity evaluation of nanocarriers for the oral delivery of macromolecular drugs.
Ojer P; Iglesias T; Azqueta A; Irache JM; López de Cerain A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):206-17. PubMed ID: 26493712
[TBL] [Abstract][Full Text] [Related]
2. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
Hunter AC; Elsom J; Wibroe PP; Moghimi SM
Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules.
Chen MC; Mi FL; Liao ZX; Hsiao CW; Sonaje K; Chung MF; Hsu LW; Sung HW
Adv Drug Deliv Rev; 2013 Jun; 65(6):865-79. PubMed ID: 23159541
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers protecting toward an intestinal pre-uptake metabolism.
Suchaoin W; Bernkop-Schnürch A
Nanomedicine (Lond); 2017 Feb; 12(3):255-269. PubMed ID: 28093952
[TBL] [Abstract][Full Text] [Related]
5. Is nanotechnology a boon for oral drug delivery?
Agrawal U; Sharma R; Gupta M; Vyas SP
Drug Discov Today; 2014 Oct; 19(10):1530-46. PubMed ID: 24786464
[TBL] [Abstract][Full Text] [Related]
6. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.
Araújo F; Shrestha N; Granja PL; Hirvonen J; Santos HA; Sarmento B
Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):381-93. PubMed ID: 25495133
[TBL] [Abstract][Full Text] [Related]
7. Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication.
Shahbazi MA; Santos HA
Curr Drug Metab; 2013 Jan; 14(1):28-56. PubMed ID: 22497568
[TBL] [Abstract][Full Text] [Related]
8. Influence of drug molecular weight on self-assembly and intestinal permeation of polymer-based nanocarriers.
Schreiner J; Rindt C; Wächter J; Jung N; Vogel-Kindgen S; Windbergs M
Int J Pharm; 2023 Nov; 646():123483. PubMed ID: 37802258
[TBL] [Abstract][Full Text] [Related]
9. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
Hunter AC; Elsom J; Wibroe PP; Moghimi SM
Maturitas; 2012 Sep; 73(1):5-18. PubMed ID: 22709523
[TBL] [Abstract][Full Text] [Related]
10. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
Mei L; Zhang Z; Zhao L; Huang L; Yang XL; Tang J; Feng SS
Adv Drug Deliv Rev; 2013 Jun; 65(6):880-90. PubMed ID: 23220325
[TBL] [Abstract][Full Text] [Related]
12. Engineering strategies to enhance nanoparticle-mediated oral delivery.
Yamanaka YJ; Leong KW
J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
[TBL] [Abstract][Full Text] [Related]
13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
14. Lipid-based nanocarriers for the oral administration of biopharmaceutics.
Karamanidou T; Bourganis V; Kammona O; Kiparissides C
Nanomedicine (Lond); 2016 Nov; 11(22):3009-3032. PubMed ID: 27781558
[TBL] [Abstract][Full Text] [Related]
15. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
Moritz M; Geszke-Moritz M
Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
[TBL] [Abstract][Full Text] [Related]
16. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies.
Galindo-Rodriguez SA; Allemann E; Fessi H; Doelker E
Crit Rev Ther Drug Carrier Syst; 2005; 22(5):419-64. PubMed ID: 16313233
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery.
Iglesias T; López de Cerain A; Irache JM; Martín-Arbella N; Wilcox M; Pearson J; Azqueta A
Int J Pharm; 2017 Jan; 517(1-2):67-79. PubMed ID: 27908629
[TBL] [Abstract][Full Text] [Related]
18. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery.
Roger E; Lagarce F; Garcion E; Benoit JP
Nanomedicine (Lond); 2010 Feb; 5(2):287-306. PubMed ID: 20148639
[TBL] [Abstract][Full Text] [Related]
19. Polymeric micelles for oral drug delivery.
Gaucher G; Satturwar P; Jones MC; Furtos A; Leroux JC
Eur J Pharm Biopharm; 2010 Oct; 76(2):147-58. PubMed ID: 20600891
[TBL] [Abstract][Full Text] [Related]
20. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
Dilnawaz F
Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
